Labelling Pharmaceutical Companies Vaccines 
pharmaphorum
FEBRUARY 9, 2022
In this article, Ben Hargreaves looks into the promise of cancer vaccines and how this treatment modality may offer advantages over existing immunotherapies in the oncology sector. The oncology segment has been recognised as one of the most productive areas for pharmaceutical companies to focus their R&D investment.
pharmaphorum
DECEMBER 16, 2022
Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid. Vaccine access for a price. Tendayi Achium, labelled the response by the global community as a form of “vaccine apartheid,” a suggestion echoed by the organisation’s director general.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The People's Pharmacy
MAY 29, 2023
According to my European colleagues it is prescribed off-label for this purpose. A reader of this column notified us several years ago that his medical colleagues in Europe prescribed cimetidine off label to treat shingles and z oster- a ssociated p ain ( ZAP ). We searched high and low for research to support this unique strategy.
The Checkup by Singlecare
MAY 16, 2024
Healthcare providers sometimes prescribe it for off-label uses as well, including for severe forms of sarcoidosis, pustular psoriasis, and COVID-19. The FDA has placed boxed warnings on Remicade’s drug label , calling attention to the risk of serious infections, like tuberculosis and fungal infections.
pharmaphorum
OCTOBER 7, 2021
That is of paramount importance in medical education, “where a lot of the discussions between the KOLs in the sessions are about off-label content.” ” That means providers have to make sure that they exclude HCPs from countries that aren’t allowed to get off-label content directly from a pharma company.
PharmaShots
FEBRUARY 21, 2023
Market Cap: $10.67M Founded Year: 2009 Total Employees: ~410 Headquarters: Colorado, United States Stock Exchange: OTCMKTS Clovis Oncology is a biopharma company that develops and delivers anti-cancer agents to the US, EU, and other international markets.
ISPE
SEPTEMBER 29, 2023
For more than 240 years, Takeda has focused on delivering transformative treatments in the therapeutic areas of gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines.
Expert insights. Personalized for you.
134 
Let's personalize your content